ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SWKH SWK Holdings Corporation

17.01
-0.26 (-1.51%)
Apr 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 3,294
Bid Price 6.80
Ask Price 21.35
News -
Day High 17.08

Low
15.26

52 Week Range

High
18.75

Day Low 16.87
Company Name Stock Ticker Symbol Market Type
SWK Holdings Corporation SWKH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.26 -1.51% 17.01 20:00:00
Open Price Low Price High Price Close Price Prev Close
17.07 16.87 17.08 17.01 17.27
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
128 3,294 $ 16.97 $ 55,897 - 15.26 - 18.75
Last Trade Time Type Quantity Stock Price Currency
16:00:23 35 $ 17.01 USD

SWK Holdings Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
312.58M 12.50M - 44.06M 15.89M 1.27 19.68
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

SWK News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SWKH Message Board. Create One! See More Posts on SWKH Message Board See More Message Board Posts

Historical SWKH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week17.2017.7416.7817.386,880-0.19-1.10%
1 Month17.9318.027716.6617.177,752-0.92-5.13%
3 Months17.5218.48815.9217.1910,930-0.51-2.91%
6 Months15.8918.7515.6517.139,0121.127.05%
1 Year17.4218.7515.2616.809,329-0.41-2.35%
3 Years16.6520.494515.2617.9715,1460.362.16%
5 Years14.0020.49456.1216.8914,4003.0121.50%

SWK Description

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

Your Recent History

Delayed Upgrade Clock